Parametric Tolerance Interval Testing Working Group To Deliver Findings By Year-End
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA believes the method is an improvement over non-parametic testing but is seeking to resolve outstanding safety issues, the agency tells the Pharmaceutical Science Advisory Committee.